Literature DB >> 6601489

Phospholipase activities of bronchoalveolar lavage fluid in rat Pneumocystis carinii pneumonia.

S Kernbaum, J Masliah, L G Alcindor, C Bouton, D Christol.   

Abstract

Respiratory distress, main clinical symptom of P. carinii pneumonia, is unexplained. We wondered if it could be linked with a lung surfactant anomaly. We have shown in the bronchoalveolar fluid lavage of P. carinii-infected rats: a very significant decrease of the phospholipid content; a lowering of the phospholipid/protein ratio; and an increase in phospholipase activities, partly due to the activation of an inactive phospholipase into the active form. We conclude that, in P. carinii-infected rats, there is an increased catabolism of lung surfactant.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601489      PMCID: PMC2040788     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  12 in total

1.  [Comparative study on colorimetric determination of phosphorus; research on a highly sensitive method applicable to the determination of organic phosphorus in chromatographic spots].

Authors:  J L DELSAL; H MANHOURI
Journal:  Bull Soc Chim Biol (Paris)       Date:  1955

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Group B streptococcal type Ia sepsis in mice after intranasal inoculation and the effect of infection on lungs.

Authors:  D E Wennerstrom
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

4.  Pneumocystis carinii pneumonia.

Authors:  W T Hughes
Journal:  N Engl J Med       Date:  1977-12-22       Impact factor: 91.245

5.  Hyaline membrane disease. II. Lung lecithin.

Authors:  K Boughton; G Gandy; D Gairdner
Journal:  Arch Dis Child       Date:  1970-06       Impact factor: 3.791

6.  [Activities of pulmonary phospholipases of fetal rats. Variations during development].

Authors:  B Melin; R Maximilien; G Friedlander; J Etienne; L G Alcindor
Journal:  Biochim Biophys Acta       Date:  1977-03-25

7.  Pneumocystis pneumonia. Animal model: pneumocystis cartinii pneumonia in the immunosuppressed rat.

Authors:  F W Chandler; J K Frenkel; W G Campbell
Journal:  Am J Pathol       Date:  1979-05       Impact factor: 4.307

8.  [Phospholipase A2 activity in rat serum. Association of two proteins (author's transl)].

Authors:  J Etienne; A Grüber; J Polonovski
Journal:  Biochim Biophys Acta       Date:  1980-09-08

9.  Mechanism of pulmonary alveolar injury in experimental Pneumocystis carinii pneumonia in the rat.

Authors:  K Yoneda; P D Walzer
Journal:  Br J Exp Pathol       Date:  1981-08

10.  Interaction of Pneumocystis carinii with host lungs: an ultrastructural study.

Authors:  K Yoneda; P D Walzer
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

View more
  11 in total

Review 1.  Aids and the lung. 6-- Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

2.  Sterols of Pneumocystis carinii hominis organisms isolated from human lungs.

Authors:  E S Kaneshiro; Z Amit; J Chandra; R P Baughman; C Contini; B Lundgren
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

3.  Down-regulation of GATA-2 transcription during Pneumocystis carinii infection.

Authors:  X Tang; M E Lasbury; D D Davidson; M S Bartlett; J W Smith; C H Lee
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

Review 4.  The lipids of Pneumocystis carinii.

Authors:  E S Kaneshiro
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Effect of surfactant replacement on Pneumocystis carinii pneumonia in rats.

Authors:  E P Eijking; G J van Daal; R Tenbrinck; A Luijendijk; J F Sluiters; E Hannappel; B Lachmann
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

6.  Phospholipid composition of Pneumocystis carinii carinii and effects of methylprednisolone immunosuppression on rat lung lipids.

Authors:  Z Guo; E S Kaneshiro
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

7.  Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat.

Authors:  W R Rice; F M Singleton; M J Linke; P D Walzer
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia.

Authors:  P M Girard; M Brun-Pascaud; R Farinotti; L Tamisier; S Kernbaum
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

9.  Phospholipid profile of Pneumocystis carinii and its interaction with alveolar type II epithelial cells.

Authors:  E L Pesanti
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

10.  Lung mechanics, radiography and 67Ga scintigraphy in experimental Pneumocystis carinii pneumonia.

Authors:  D C Stokes; W T Hughes; P O Alderson; R E King; D J Garfinkel
Journal:  Br J Exp Pathol       Date:  1986-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.